This inventor holds 3 USPTO granted patents. Top assignees: Sanofi, Sanofi-Synthelabo. Active years: 1988-2001.
Company Filing History:
Years Active: 1988-2001
Title: The Innovative Contributions of Jean C Breliere
Introduction
Jean C Breliere is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs aimed at preventing tumor cell proliferation and anti-inflammatory products. With a total of 3 patents to his name, Breliere's work has had a meaningful impact on medical science.
Latest Patents
Breliere's latest patents include innovative methods and compounds that address critical health issues. One of his notable inventions is the use of amines to produce drugs for preventing tumor cell proliferation. This invention relates to the use of compounds capable of displacing tritiated cis-N-cyclohexyl-N-ethyl [3-(3-chloro-4-cyclohexylphenyl)-allyl]amine from its receptors for the preparation of pharmaceutical compositions intended to combat cell proliferation. Another significant patent involves anti-inflammatory products derived from methylene-diphosphonic acid. This invention pertains to products of a specific formula, where various chemical groups are utilized to create drugs with anti-inflammatory effects.
Career Highlights
Throughout his career, Jean C Breliere has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Synthelabo. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.
Collaborations
Breliere has collaborated with several professionals in his field, including Xavier Emonds-Alt and Georges Garcia. These collaborations have likely enriched his research and led to the successful development of his patented inventions.
Conclusion
Jean C Breliere's contributions to pharmaceutical innovation demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex chemical interactions and their potential applications in medicine.